Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from CentreWatch

04:32 EST 24th November 2017 | BioPortfolio

Here are the most relevant search results for "CentreWatch" found in our extensive news archives from over 250 global news sources.

More Information about CentreWatch on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about CentreWatch for you to read. Along with our medical data and news we also list CentreWatch Clinical Trials, which are updated daily. BioPortfolio also has a large database of CentreWatch Companies for you to search.

Showing News Articles 1–25 of 827 from CentreWatch

Wednesday 22nd November 2017

Khondrion presents phase II KHENERGY trial data

Khondrion, a clinical-stage pharmaceutical company focusing on small molecule therapeutics for mitochondrial diseases, announced results from its KHENERGY study, a phase II exploratory trial with oral KH176 in the m.3243A>G multisystem mitochondrial MELAS and MIDD syndromes and mixed phenotypes. The results of the trial were presented by Prof. Jan Smeitink, Khondrion’s CEO, at the Dutch ...

MediMedia Managed Markets wins awards for data analytics and healthcare communications

ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, announced that MediMedia Managed Markets, an ICON company, has received two gold industry awards in recognition of innovative customer solutions. MediMedia was awarded gold for the Best Use of Data Analytics at the 2017 Medical Marketing & Media (MM&M) [&...

Study: Clinical monitoring job turnover increased significantly outside the U.S.

In countries outside the U.S., employee turnover in clinical monitoring (the function that monitors participants’ health during a clinical trial) took a significant jump to 22.9% in 2016 from the previous year’s turnover of 16.4%, a 40% increase. Turnover in the U.S. for clinical monitoring jobs at CROs remained high at 25.8% in 2016 with […] The post Study: Clinical monitoring job turno...

Monday 20th November 2017

MRA, Inspire launch online community focused on clinical trials

The Melanoma Research Alliance (MRA), a nonprofit funder of melanoma research, in partnership with Inspire, a U.S. healthcare social network, announced the launch of Melanoma > Exchange, an online support community for anyone touched by melanoma to find support, ask questions and build community. Melanoma is the most deadly form of skin cancer. Over 87,000 Americans are […] The post MR...

IMAEH Hospital joins Clinerion’s PRS network of hospitals

The Mehmet Akif Ersoy Göğüs Kalp Damar Cerrahisi Eğitim Araştırma Hastanesi (IMAEH) hospital in Istanbul has joined the network of hospitals on Clinerion’s PRS platform. The Istanbul Mehmet Akif Ersoy Hospital provides care for all medical indications, with specialization in cardiology and pulmonology. The hospital’s catchment area has a population of 4.5 M. It is […] The post IMAE...

WIRB-Copernicus Group partners with Veeva Systems

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, is partnering with Veeva Systems to improve the speed and accuracy of institutional review board (IRB) document transfer. WCG will build a seamless connection between WCG’s MyConnexus IRB document management web portal and Veeva Vault eTMF. By linking Vault […] The...

MasterControl launches Version 11.7

MasterControl, a global provider of software solutions that enable life science and other regulated companies to deliver life-improving products to more people sooner, has released MasterControl Version 11.7 that includes powerful new analytics capabilities as well as three new cloud-based solutions, MasterControl eTMF Manager, MasterControl Registrations and MasterControl Registrations for eCTD. ...

Fasenra receives FDA approval for severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the FDA has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype. FASENRA is not approved for the treatment of other eosinophilic conditions or relief of acute bronchospasm or status asthmaticus. [&...

Science Exchange, Alector partner

Science Exchange, a secure enterprise platform and aggregator for outsourced research and development (R&D), announced a strategic partnership with Alector, a biotech company pioneering the discovery & development of immuno-neurology therapies for neurodegenerative disorders, to provide the company’s scientists access to a private R&D marketplace to accelerate their research. “...

TESARO announces EC approval of ZEJULA for recurrent ovarian cancer

TESARO, an oncology focused biopharmaceutical company, announced that the European Commission (EC) has granted marketing authorization for ZEJULA (niraparib) as a monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete response (CR) or partial response (PR) ...

CrownBio launches grant program to Fund Preclinical Oncology Research

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announced the launch of a grant program supporting oncology research scientists which provides funding for projects that show promise for scienti...

Report: CTMS market hit $1,848.5M in revenue by the end of 2019

According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at $844 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to […] The post Report: CTMS market hit $1,848.5M in revenue by ...

New Oracle Cloud Infrastructure innovations

Oracle announced the general availability of a range of new Oracle Cloud Infrastructure compute options, providing customers with unparalleled compute performance based on Oracle’s recently announced X7 hardware. Newly enhanced virtual machine (VM) and bare metal compute, and new bare metal graphical processing unit (GPU) instances enable customers to run even the most infrastructure-heavy workl...

Friday 17th November 2017

Fasenra (Benralizumab) receives FDA approval for severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the FDA has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype. FASENRA is not approved for the treatment of other eosinophilic conditions or relief of acute bronchospasm or status asthmaticus. [&...

FDA gives clearance for opioid addiction withdrawal treatment

The FDA gave clearance  for a neurological device with an indication to aid in the reduction of opioid withdrawal symptoms. The NSS-2 BRIDGE device, pioneered by Indiana-based medical technology firm Innovative Health Solutions (IHS), is placed behind the ear with micro-needle arrays that percutaneously implant in and around the ear. Research study results of the technology […] The post FD...

Wednesday 15th November 2017

Elizabeth Iorns elected to the Board of Directors DCAT

Science Exchange, a secure enterprise platform for outsourced research and development (R&D) services, announced that Elizabeth Iorns, Ph.D., CEO of Science Exchange, has been elected to serve her first term on the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT) beginning November 1, 2017. Members of DCAT’s Board of Directors are […] The post E...

PAREXEL adds senior executives from FDA and oncology industry

PAREXEL, a global biopharmaceutical services provider, announced the appointment of three former senior regulatory consulting executives from the FDA and Oncology industry positions. The new hires are part of PAREXEL’s Global Integrated Product Development and Compliance team and will be focused on helping PAREXEL clients deliver commercially viable, reimbursable products to market faster and mo...

Quotient Sciences acquires U.K CDMO Pharmaterials

Quotient Sciences, a drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K. The acquisition strengthens and expands Quotient’s formulation and manufacturing services footprint in the U.K., and further supports the growth of Quotient’s Translational Pharmaceutics platform, following ...

Purdue Pharma invests in oncology R&D

Purdue Pharma announced completion of significant oncology related investments as part of its ongoing efforts to diversify its scientific research into areas of high unmet medical need. Through these investments, executed over a multi-year period and capped recently in 2017, Purdue is establishing a portfolio of drug candidates with the potential to deliver new cancer therapies to […] The ...

Tuesday 14th November 2017

FDA approves pill with sensor to track patients adherence

The FDA approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar […] The post FDA approves pill with sens...

Sage’s postpartum depression drug Brexanolone hits primary endpoints

Sage Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced positive top-line results from two phase III clinical trials with its proprietary i.v. formulation of brexanolone (USAN; formerly SAGE-547); Study 202B in severe postpartum depression (PPD) and Study 202C in moderate PPD. Brexanolone achi...

Bracket Strengthens adds New Chief Commercial Officer Christopher Crucitti

Bracket, a clinical trial technology and specialty services provider, added Christopher Crucitti, Chief Commercial Officer to its global executive team. Crucitti joins Bracket as an experienced commercial leader in clinical and R&D services. Crucitti brings industry-recognized experience, knowledge and integrity to Bracket’s leadership team as well as notable accomplishments in training...

NCPA statement on nomination of Alex Azar to be HHS Secretary

National Community Pharmacists Association CEO B. Douglas Hoey, Pharmacist, MBA, issued the following statement on President Donald Trump’s nomination of Alex Azar, a former executive at Eli Lilly & Co., to lead the U.S. Department of Health and Human Services: “We congratulate Alex Azar on his nomination to be the next HHS Secretary. His background […] The post NCPA statement on nom...

Pertinax Pharma appoints former Sanofi chairman Nigel Brooksby as Chairman

Pertinax Pharma announces that Nigel Brooksby has been appointed as chairman of the company. His chief responsibilities will be to assist in corporate, strategic and business development moves into its commercialization phase following the launch last month of Pertinax. This unique technology which enables controlled and sustained release of the antimicrobial, chlorhexidine (CHX) has wide […...

Horizon Discovery’s Dharmacon introduces Edit-R CRISPRa reagent platform

Horizon Discovery, a global leader in gene editing and gene modulation technologies, announced the launch of its reagent platform for CRISPR activation (CRISPRa) from its recently acquired Dharmacon business. This is the latest addition to the Company’s market-leading Edit-R portfolio for CRISPR-Cas9 genome engineering. The new Edit-R CRISPRa offering provides researchers interested in gain-of-f...


Quick Search
Advertisement
 

News Quicklinks